Akademischer Bericht 2007 Institut für Klinische Chemie

Serra AL, Savoca R, Huber AR, Hepp U, Delsignore A, Hersberger M, Wüthrich RP (2007): Effective
control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients In: Nephrology,
dialysis, transplantation 22(2), 577-83
Shamshiev AT, Ampenberger F, Ernst B, Rohrer L, Marsland BJ, Kopf M (2007): Dyslipidemia inhibits
Toll-like receptor-induced activation of CD8alpha-negative dendritic cells and protective Th1 type immunity
In: The journal of experimental medicine 204(2), 441-52
Shayanfar N, Tobler U, von Eckardstein A, Bestmann L (2007): Automated urinalysis: frist experiences
and a comparison between the Iris IQ200 urine microscopy system, the Sysmex UF-100 flow cytometer
and manual microscopic particle counting In: Clinical chemistry and laboratory medicine : CCLM /
FESCC 45(9), 1251-6
Spanaus KS, Kronenberg F, Ritz E, Schlapbach R, Fliser D, Hersberger M, Kollerits B, König P, von
Eckardstein A, (2007): B-type natriuretic peptide concentrations predict the progression of nondiabetic
chronic kidney disease: the Mild-to-Moderate Kidney Disease Study In: Clinical chemistry 53(7), 1264-72
Turello R, Rentsch K, Di Paolo E, Popovic MB (2007): Renal failure after high-dose methotrexate in a
child homozygous for MTHFR C677T polymorphism In: Pediatric blood & cancer 50(1), 154-156
Wittwer J, Bayer M, Bosandl A, Muntwyler J, Hersberger M (2007): The c.-292C>T promoter polymorphism
increases reticulocyte-type 15-lipoxygenase-1 activity and could be atheroprotective In: Clinical
chemistry and laboratory medicine : CCLM / FESCC 45(4), 487-92
Wronska-Nofer T, Nofer JR, Stetkiewiez J, Wierzbicka M, Bolinska H, Fobker M, Schulte H, Assmann G,
von Eckardstein A (2007): Evidence for oxidative stress at elevated plasma thiol levels in chronic exposure
to carbon disulfide (CS2) and coronary heart disease In: Nutrition, metabolism, and cardiovascular
diseases 17(7), 546-53
Zaugg M, Bestmann L, Wacker J, Lucchinetti E, Boltres A, Schulz C, Hersberger M, Kälin G, Furrer
L, Hofer C, Blumenthal S, Müller A, Zollinger A, Spahn DR, Borgeat A (2007): Adrenergic receptor
genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients
undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study:
a double-blinded, placebo-controlled, multicenter trial with 1-year follow-up. In: Anesthesiology 107(1),
33-44
Weitere Beiträge (referiert)
Wittwer J, Hersberger M (2007): The two faces of the 15-lipoxygenase in atherosclerosis In: Prostaglandins,
leukotrienes, and essential fatty acids 77(2), 67-77
Weitere Beiträge (nicht referiert)
Cavelier C, von Eckardstein, A (2007): HDL and Metabolic Syndrome In: C.J. Fielding, High Density
Lipoproteins-From Basic Biology to Clinical Aspects, Wiley VCH Verlag GmbH & Co KgaA Weinheim,
445-464
Corti N, Heck A, Rentsch K, Zingg W, Pauli-Magnus C (2007): Interaction study of oral albendazole and
mebendazole with short and long term oral ritonavir in healthy volunteers In: Clinical pharmacology and
therapeutics 81, 108-109
Gutteck-Amsler U, Rentsch KM (2007): Does AM have a tumour in the pancrease? In: Chimia 61, 199
Gutteck-Amsler U, Rentsch KM (2007): Therapeutic drug monitoring of antiretroviral drugs using LC-MS
In: Therapeutic drug monitoring 29, 468
Hofker M, Calabresi L, von Eckardstein A, Heeren J, Karpe F, Kalopissis A, Kronenberg F, Kuipers F,
Lindstedt K, Parini P, Schuster G, van Dijk KW (2007): European Lipoprotein Club: Report of the 29th
ELC Annual Conference, Tutzing, 4-7 September 2006 In: Atherosclerosis 193(2), 461-8
Institut für Klinische Chemie
Akademischer Bericht 2007
20